Shandong Weigao Blood Purification Products Co., Ltd. (SHA:603014)
China flag China · Delayed Price · Currency is CNY
41.62
+0.02 (0.05%)
At close: Jan 23, 2026

SHA:603014 Revenue

Shandong Weigao Blood Purification Products had revenue of 971.37M CNY in the quarter ending September 30, 2025, with 23.86% growth. This brings the company's revenue in the last twelve months to 3.70B. In the year 2024, Shandong Weigao Blood Purification Products had annual revenue of 3.60B with 2.03% growth.

Revenue (ttm)
3.70B
Revenue Growth
+2.03%
P/S Ratio
4.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
17.39B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20243.60B71.87M2.03%
Dec 31, 20233.53B106.03M3.09%
Dec 31, 20223.43B515.59M17.71%
Dec 31, 20212.91B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition